The Palo Alto-based company, a subsidiary of DuPont, generated over $350 million in revenue in 2002 and operates in two markets: bioproducts and healthcare. In the bioproducts market, Genencor develops and sells biocatalysts and other biochemicals for industrial, consumer, and agri-processing markets. In the healthcare market, the company focuses on drug development platforms in protein therapeutics and immunotherapeutics targeting viral infectious diseases and cancer. Genencor's technology platforms include gene discovery and functional genomics, molecular evolution and design, metabolic pathway engineering, immunology, and biomaterial production and formulation delivery systems. The company's innovative products have established it as a leader in the industry.